All News

Page 3 of 10

PD-1 vs PD-L1 Therapy in Advanced Merkel Cell Carcinoma
PD-1 vs PD-L1 Therapy in Advanced Merkel Cell Carcinoma
slu campus
Welcome Rosita, new MC3 Clinical Trial Coordinator
Rosita headshot
Welcome Rosita, new MC3 Clinical Trial Coordinator
Clinical Trial Feature: IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced MCC
Clinical Trial Feature: IFx-Hu2.0 Followed By Pembrolizumab…
MC3 Memos Newsletter | Vol. 3 (October 2025)
MC3 Memos Newsletter | Vol. 3 (October 2025)
2026 NCCN Guidelines
2026 NCCN Guidelines
MC3 Member Spotlight: Isaac Brownell, MD, PhD
Isaac Brownell, MD PhD
MC3 Member Spotlight: Isaac Brownell, MD, PhD